Roper, Rachel2019-12-022019-12-022012-11-22US Pat# US20120294896A1http://hdl.handle.net/10342/7551The present invention provides methods and compositions for modulating an immune response in a subject, comprising administering to the subject an effective amount of an A35R protein or active fragment thereof of vaccinia virus or other poxvirus.en-USgeneticGene therapycellvacciniaPatent